Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial
...e United States Food and Drug Administration later this year. "The new dural substitute, DuraTech, provides a unique solution for surgeons," said Dr. Ca...ds. Based on available data, Osteotech estimates that the annual market for dural repair substitutes is approximately $100 million. In addition to Du...Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix
...inical flexibility to cut, shape and suture the material to fit each patient's needs. Based on available data, Osteotech estimates that the market for dural repair substitutes is approximately $100 million. In addition to the DuraTech BioRegeneration Matrix, which is expected to launch late this year...Collagen Matrix, Inc. Launches OssiMend(TM) Bone Graft Matrix for Orthopedic and Spine Applications
...hips with some of the world's major medical device companies. In addition to OssiMend, Collagen Matrix's marketed products include: DuraMatrix(TM) for dural repair, Neuroflex(TM), NeuroMatrix(TM) for peripheral nerve repair, Collagen Dental Membrane, Anorganic Bone Mineral, and SynOss(TM) for oral bone rep...